Status:
WITHDRAWN
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
Lead Sponsor:
Novartis
Collaborating Sponsors:
Novartis Vaccines
Conditions:
Influenza
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The present study aims to evaluate safety and immunogenicity of one dose of a commercially available Surface Antigen, Inactivated Influenza Vaccine, Formulation 2006-2007, in non-elderly adult and eld...
Eligibility Criteria
Inclusion
- Male and female subjects 18 years of age or older
Exclusion
- any auto-immune disease or other serious acute, chronic or progressive disease
- hypersensitivity to eggs, chicken protein, chicken feathers, influenza viral protein, neomycin or polymyxin or any other component of the vaccine
- known or suspected (or high risk of developing) impairment/alteration of immune function
- within the past 7 days any acute disease or infections requiring systemic antibiotic or antiviral therapy
- history of neurological symptoms or signs, or anaphylactic shock following administration of any vaccine
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00342940
Start Date
October 1 2006
Last Update
April 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chiltern International Limited , Chiltern Place, Upton Road
Slough, United Kingdom, SL1 2AD